Results 1 to 10 of about 1,777 (151)

Interleukin-18 and IL-18BP in inflammatory dermatological diseases [PDF]

open access: yesFrontiers in Immunology, 2023
Interleukin (IL)-18, an interferon-γ inducer, belongs to the IL-1 family of pleiotropic pro-inflammatory factors, and IL-18 binding protein (IL-18BP) is a native antagonist of IL-18 in vivo, regulating its activity.
Xian Jiang, Lian Wang, Gu He
exaly   +6 more sources

Inherited IL-18BP deficiency in two Egyptian siblings with fulminant viral hepatitis [PDF]

open access: yesJ Hum Immun
A previous report described an inherited deficiency of IL-18BP, a soluble antagonist of IL-18, in an Algerian patient who died of fulminant viral hepatitis (FVH) A. We report here an Egyptian family with two siblings who died from FVH following infection
Aysima Atilgan Lülecioğlu   +2 more
exaly   +6 more sources

IL-18BP mediates the balance between protective and pathological immune responses to Toxoplasma gondii. [PDF]

open access: yesCell Rep, 2023
Summary: Interleukin-18 (IL-18) promotes natural killer (NK) and T cell production of interferon (IFN)-γ, a key factor in resistance to Toxoplasma gondii, but previous work has shown a limited role for endogenous IL-18 in control of this parasite ...
Clark JT   +10 more
europepmc   +4 more sources

Enhanced Expression of IL-18 and IL-18BP in Plasma of Patients with Eczema: Altered Expression of IL-18BP and IL-18 Receptor on Mast Cells. [PDF]

open access: yesMediators Inflamm, 2017
IL-18 has been found to be associated with eczema. However, little is known of the role of IL-18 binding protein (BP) and IL-18 receptor (R) in eczema.
Hu Y   +7 more
europepmc   +5 more sources

Clinical significance of serum IL-18 and IL-18BP in patients with benign or malignant primary liver tumors

open access: yesClinical Oncology and Cancer Research, 2009
OBJECTIVE To study the relationship between the serum levels of IL-18 and IL-18BP in the development and growth of primary liver cancer, benign liver tumors and liver cirrhosis and to determine the value of serum IL-18 and IL-18BP in the diagnosis of
Xianghui LIAO   +2 more
exaly   +4 more sources

IL-18BP Improves Early Graft Function and Survival in Lewis-Brown Norway Rat Orthotopic Liver Transplantation Model. [PDF]

open access: yesBiomolecules, 2022
Interleukin-18 (IL-18) can effectively activate natural killer (NK) cells and induce large concentrations of interferon-γ (IFN-γ). In healthy humans, IL-18 binding protein (IL-18BP) can inhibit the binding of IL-18 to IL-18R and counteract the biological
Meng Q   +6 more
europepmc   +2 more sources

[Mechanisms by which interleukin-18 binding protein regulates the NLRP3 inflammasome in Kawasaki disease-related coronary artery lesions]. [PDF]

open access: yesZhongguo Dang Dai Er Ke Za Zhi
Kawasaki disease (KD) is an acute febrile illness characterized by systemic vasculitis, with coronary artery lesion (CAL) representing its most serious complication.
Xu W, Wang S, Li TH.
europepmc   +2 more sources

IL-18 Binding Protein, a biomarker of strength maintenance after surgery but reduced physical performance in age-related sarcopenia. [PDF]

open access: yesPLoS One
Inflammation is thought to contribute to muscle loss in acute and chronic sarcopenia. Which inflammatory proteins contribute to sarcopenia in any condition is not clear.
Paul R   +7 more
europepmc   +2 more sources

Elevated plasma IL-37, IL-18, and IL-18BP concentrations in patients with acute coronary syndrome. [PDF]

open access: yesMediators Inflamm, 2014
Objective. More recently, evidence showed that the novel anti-inflammatory cytokine interleukin- (IL-) 37 was expressed in the foam-like cells of atherosclerotic coronary and carotid artery plaques, suggesting that IL-37 is involved in atherosclerosis ...
Ji Q   +11 more
europepmc   +2 more sources

IL-18 and MIG increase one year after transition to dolutegravir-based dual therapy despite sustained viral suppression. [PDF]

open access: yesFront Immunol
IntroductionModern antiretroviral treatment allowed a significant improvement in the life expectancy of people with HIV (PWH), exhibiting robust and sustained efficacy with scarce toxicities, both in two-drug regimens (2DRs) and three-drug regimens (3DRs)
Pérez-González A   +6 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy